Cover Image

The steroid receptor coactivators are targets for reactivation of HIV latency

Saved in:

Bibliographic Details
Main Authors:	B.C. Nikolai (Author), Q. Feng (Author), R.B. York (Author), C.E. Foulds (Author), E.B. Siwak (Author), D.M. Lonard (Author), A.P. Rice (Author), B.W. O'Malley (Author)
Format:	Book
Published:	Elsevier, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Regulation of HIV-1 provirus and CD4+ T cell biology by transcriptional coregulators
by: B.C. Nikolai, et al.
Published: (2017)

SRC-2 Coactivator: a role in human metabolic evolution and disease
by: Bert W. O'Malley
Published: (2020)

Degradation of the XPB subunit of TFIIH by spironolactone reduces HIV-1 reactivation from latency
by: L. Mori, et al.
Published: (2019)

Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: A. Ward, et al.
Published: (2017)

Single cell analysis of HIV latency reveals diverse proviral and host cell behaviour
by: E.P. Browne, et al.
Published: (2017)

Induction of HIV from latency by a novel molecule
by: N.M. Archin, et al.
Published: (2015)

Epigenomic characterisation of a primary cell model of HIV latency
by: E. Browne, et al.
Published: (2019)

Identification of isoform-selective hydroxamic acid derivatives that potently reactivate HIV from latency
by: Elleard F.W. Heffern, et al.
Published: (2019)

SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo
by: R.M. Dunham, et al.
Published: (2017)

The Hippo Coactivator TAZ Exacerbates Cisplatin-Induced Acute Renal Injury
by: Xian Xue, et al.
Published: (2024)

SMAC mimetics reverse HIV latency by selective activation of the non-canonical NF-κB pathway
by: G.C. Sampey, et al.
Published: (2017)

Shining the RNA-Seq microscope on models of HIV latency
by: C.H. Woelk, et al.
Published: (2015)

Visualisation of HIV reactivation from latency in primary resting memory T-cells
by: F. Kizito, et al.
Published: (2019)

Leptin recruits Creb-regulated transcriptional coactivator 1 to improve hyperglycemia in insulin-deficient diabetes
by: Geun Hyang Kim, et al.
Published: (2015)

PP 2.3 - 00034 CD8+ T-Cell Sieving During SIV Reactivation from Latency
by: S. Docken, et al.
Published: (2022)

Galectin-1 promotes HIV-1 latency reactivation
by: J. Rubione, et al.
Published: (2019)

PP 2.9 - 00125 Impact of latency reversal agents on estrogen receptor alpha gene and protein expression
by: C. Ceriani, et al.
Published: (2022)

OA2-1 Frequent and 'burst-like' reactivation from latency in SIVmac239M infected macaques
by: M. Pinkevych, et al.
Published: (2016)

Mixed effects of HDACi on host gene expression and their implications for HIV reactivation from latency
by: N. Beliakova-Bethell, et al.
Published: (2015)

Developing an in vitro model for HIV-1 latency in Tfh cells using tonsillar tissue
by: B. Luttge, et al.
Published: (2017)

Expression of Nuclear Receptor Coactivators in the Human Fetal Membranes at Term before and after Labor
by: Che-Wei Ryan Ou, et al.
Published: (2012)

The unique enrichment of histone modifications and its relationship with HIV-1 latency in some chromosomes
by: K.C. Kim, et al.
Published: (2015)

Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART
by: A.A. Okoye, et al.
Published: (2019)

11 Identification of a new host cell HDAC complex that controls HIV latency through direct binding to the core promoter
by: E. Wilhelm, et al.
Published: (2016)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

Latency reactivating agents: impact on human macrophages physiology and susceptibility to HIV-1 infection
by: L. Hany, et al.
Published: (2019)

Herpesvirus Latency
Published: (2020)

Insights into mechanisms of HIV reactivation from latency using RNA-Seq gene expression profiling in CD4+ T cells and their maturation subsets following treatment with latency reversing agents.
by: N. Beliakova-Bethell, et al.
Published: (2017)

Leupaxin promotes hepatic gluconeogenesis and glucose metabolism by coactivation with hepatic nuclear factor 4α
by: Xiaomin Luo, et al.
Published: (2025)

Targeted screens identify new chromatin regulators of HIV latency
by: A.-M. Turner, et al.
Published: (2017)

Evaluation of HIV latency reversal using designed PKC modulators in humanized BLT mice
by: M.D. Marsden, et al.
Published: (2015)

Lack of transcriptional latency in infected primary cells in the presence of exosomes and cART
by: C. DeMarino, et al.
Published: (2017)

The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ
by: Tao Liu, et al.
Published: (2021)

Transcription Coactivator BCL3 Acts as a Potential Regulator of Lipid Metabolism Through the Effects on Inflammation
by: Zhang S, et al.
Published: (2021)

New biomarkers of latency
by: Christina Psomas
Published: (2018)

Low viral reservoir treated individuals show unusual HIV latency distribution
by: C. Gálvez, et al.
Published: (2019)

Estrogen potently blocks HIV re-emergence from latency and points to gender-specific differences in HIV reservoirs and novel cure strategies
by: J. Karn, et al.
Published: (2015)

Transcription factor EHF interacting with coactivator AJUBA aggravates malignancy and acts as a therapeutic target for gastroesophageal adenocarcinoma
by: Li Peng, et al.
Published: (2024)

PGC-1 coactivators in β-cells regulate lipid metabolism and are essential for insulin secretion coupled to fatty acids
by: Daniel Oropeza, et al.
Published: (2015)

Lower limb muscle coactivation levels in healthy younger and older adults during functional dual-task gait
by: Camilla Zamfolini Hallal, et al.
Published: (2013)